Guosheng Yang
Overview
Explore the profile of Guosheng Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin N, Zheng J, Yang G, Kim E, Kurihara O
Talanta
. 2025 Feb;
289:127768.
PMID: 39999731
Plutonium (Pu) isotopes are extremely hazardous radioactive materials. Rapid analysis of Pu in urine from contaminated persons is important for radiobiological verification and exposure dose assessment. Since Pu is classified...
2.
Huang L, Li D, Yan Y, Li R, Huang J, Ye J, et al.
J Int Med Res
. 2025 Feb;
53(2):3000605251315921.
PMID: 39956618
Complete staghorn calculi present one of the most challenging conditions in managing upper urinary tract stones. The complexity of treatment increases significantly when combined with severe scoliosis, particularly in patients...
3.
Li Z, Xin S, Huang L, Tian Y, Chen W, Liu X, et al.
Oncogene
. 2025 Jan;
44(10):709.
PMID: 39843565
No abstract available.
4.
Li Z, Xin S, Huang L, Tian Y, Chen W, Liu X, et al.
Oncogene
. 2024 Dec;
44(10):665-678.
PMID: 39639172
Clear cell renal cell carcinoma (ccRCC) is one of the most common malignancies. Recently, the role of brain-expressed X-linked 4 (BEX4) in cancer progression has received increasing attention. This study...
5.
Su H, Huang L, Zhou J, Yang G
Front Cell Dev Biol
. 2024 Aug;
12:1410102.
PMID: 39175878
Prostate cancer (PCa) is the most common malignancy among men worldwide. Through androgen receptor signaling inhibitor (ARSI) treatment, patients eventually succumb to castration-resistant prostate cancer (CRPC). For this, the prostate...
6.
Yang B, Zheng J, Yang G, Qin N, Tagami K, Uchida S
J Environ Radioact
. 2024 Jul;
278:107506.
PMID: 39053127
For the quality control in determining transuranic nuclides in fallout samples, this work first reported the Np activity concentration in a reference fallout material and further calculated the activity ratios...
7.
Ma W, Ge Q, Guan Y, Zhang L, Huang L, Chen L, et al.
Transl Oncol
. 2024 Jun;
47:102042.
PMID: 38924847
Clear cell renal cell carcinoma (ccRCC) is a common urological malignancy that is involved in tumor genesis and development. However, few studies have focused on the predictive role of the...
8.
Xin S, Zhang Y, Zhang Z, Li Z, Sun X, Liu X, et al.
Cancer Gene Ther
. 2024 Jun;
31(8):1201-1220.
PMID: 38877164
Metastasis is the greatest clinical challenge for UTUCs, which may have distinct molecular and cellular characteristics from earlier cancers. Herein, we provide single-cell transcriptome profiles of UTUC para cancer normal...
9.
Wen J, Wang X, Yang G, Zheng J
Heliyon
. 2024 Apr;
10(8):e27959.
PMID: 38655290
AURKA is a member of the serine/threonine kinase family and its kinase activity is crucial for the progression of mitosis. Recent studies have highlighted the therapeutic significance of AURKA inhibition...
10.
Li Z, Tian Y, Zong H, Wang X, Li D, Keranmu A, et al.
Apoptosis
. 2024 Mar;
29(7-8):1051-1069.
PMID: 38553613
Dysregulation of deubiquitination contributes to various diseases, including cancer, and aberrant expression of deubiquitinating enzymes is involved in carcinoma progression. As a member of the ovarian tumor (OTU) deubiquitinases, OTUD4...